insights_auto
Why is LYEL down 2.67%?
Dive Deeperchevron_right
LYEL:NASDAQ
Lyell Immunopharma Inc
$9.85
arrow_downward
-2.67%(-0.27) 1D
$9.85
0.00% (0.00)
bedtimeAfter hours
Closed: Sep 25, 4:00:01 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for LYEL...
Open
$10.16
High
$10.16
Low
$9.81
Mkt. cap
241.38M
Avg. vol.
132.60K
Volume
108.90K
52-wk high
$45.00
52-wk low
$9.81
EPS
-$12.01
Beta
-0.04
Shares outstanding
24.50M
No. of employees
161
Open
$10.16
High
$10.16
Low
$9.81
Mkt. cap
241.38M
Avg. vol.
132.60K
Volume
108.90K
52-wk high
$45.00
52-wk low
$9.81
EPS
-$12.01
Beta
-0.04
Shares outstanding
24.50M
No. of employees
161
Profile
Lyell Immunopharma, Inc. is an American clinical-stage biopharmaceutical company headquartered in San Francisco, California. Founded in 2018, the company develops next-generation cell therapies, including CAR T cell, using technologies intended to improve T-cell persistence, function, and resistance to exhaustion. Its pipeline includes therapies being developed for hematologic malignancies and solid tumors. Wikipedia
About Lyell Immunopharma Inc
CEO-
Employees161
Founded2018
HeadquartersSouth San Francisco, California, United States
SectorBiotechnology
Websitelyell.com